MAPT and Alzheimer disease: AD GWAS have also found evidence that specific biological processes, or disease pathways, such as cell trafficking, beta amyloid production, tau protein regulation and cholesterol transport are involved (Jones et al., 2010; Kunkle et al., 2019).